Call for Conflict Hub

Biomedical groups propose a simplified system for the disclosure of potential conflicts of interests.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Flickr, CarbonNYCIn a bid to increase transparency about researchers’ conflicts of interest, a group of biomedical institutions last week (November 28) proposed creating a central database to house all potential conflict data, and a harmonized system for disclosure. Outlined in a paper published in the Journal of the American Medical Association, the database would hold records about fees for services, intellectual property rights, industry grants, and ownership stakes, as well as payments for food, travel, and lodging.

“A coherent, uniform system will not only reduce the time spent by researchers on administrative tasks, but will very likely improve the accuracy and clarity of disclosure reporting,” Allen Lichter, lead author of the paper and CEO at the American Society of Clinical Oncology, said in a statement.

The proposal comes shortly before the “sunshine” provisions of the Affordable Care Act comes into effect next year—a law that requires drug manufacturers to publish on their company websites any payments to physicians and researchers of $10 or greater. The law would add another layer of disclosure requirements to an already confused and complicated process, said the authors. To reduce the administrative burden and increase accessibility to disclosure records, representatives of several institutes including the US Food ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies